Archive: Cannabis Report
Page:
Cannabis Report: Pot Stocks Are Starting to Rebound
By Early Investing on January 23, 2020
Pot stocks have gotten hammered over the last few months. But prices are starting to rebound. And three catalysts are responsible for the upswing.
Cannabis Report: Why You Should Own These Five Cannabis Stocks
By Early Investing on November 14, 2019
In this special edition of the Cannabis Report, Adam Sharp joins us to explain why he’s so excited about the new First Stage Investor cannabis portfolio.
Cannabis Report: Uncertainty Should Be Baked Into the Market
By Early Investing on October 17, 2019
The cannabis industry is taking it too personally when just one or two companies have a bad day. Fortunately, there are buying opportunities amid the bad news.
Cannabis Report: Two Wild Cards Might Block the SAFE Banking Act
By Early Investing on October 3, 2019
The House made history last week when it passed the first marijuana reform law ever. But there are a couple of reasons why this bill may not make it past the Senate.
Cannabis Report: Don’t Get Hung Up on Aurora’s Small Mistakes
By Early Investing on September 19, 2019
Aurora Cannabis missed its own guidance in its quarterly earnings report. But we’re not too worried about it. Here’s why.
Cannabis Report: Invest for the Long Term
By Early Investing on September 5, 2019
Cannabis stocks are having a rough year. But that’s no reason to get out of the market.
Cannabis Report: There’s No Cutting Corners With Compliance
By Early Investing on August 22, 2019
Investors need to pay close attention to cannabis companies’ attitude toward compliance. If they’re cutting corners... it’s not a good sign.
Cannabis Report: One of the Most Important Lessons for Cannabis Investors
By Early Investing on August 8, 2019
In order to succeed, cannabis investors need to learn a very important lesson about industry regulations.
Cannabis Report: Curaleaf Grows by Acquisition
By Early Investing on July 25, 2019
Curaleaf is growing the only way it can. And it’s nothing to sniff at.
Cannabis Report: A Guide to Canopy Growth’s Earnings Report
By Early Investing on July 11, 2019
Canopy Growth's earnings report wasn’t exactly full of surprises, but its stock price still had a strong reaction. Here’s why.
Cannabis Report: MedMen Expanding Into Florida
By Early Investing on June 20, 2019
This week in weed, MedMen begins its ambitious Florida expansion, Texas takes a big step forward and New York stumbles in its attempt to legalize recreational marijuana before the end of its legislative session.
Cannabis Report: Illinois Legalizes Recreational Marijuana, FDA Talks CBD
By Early Investing on June 6, 2019
There’s big news out of Illinois and the FDA this week. Illinois legalized recreational marijuana and the FDA had a hearing on CBD regulations.
Cannabis Report: How to Analyze Cannabis Companies’ Earnings Reports
By Early Investing on May 23, 2019
Earnings reports can reveal a lot about a company’s health. Here’s how to analyze them.
Cannabis Report: Canopy Growth’s Acreage Deal Meets Resistance; New Jersey Gets Petty
By Early Investing on May 9, 2019
Canopy Growth’s deal to buy Acreage Holdings has hit a snag, and New Jersey is mired in petty politics.
Cannabis Report: Canopy Growth Thinks Ahead While U.S. Cannabis Research Falls Behind
By Early Investing on April 25, 2019
This week in weed, an American cannabis stock makes its Nasdaq debut, Canopy Growth thinks ahead and the U.S. misses the boat on medical marijuana.
Cannabis Report: The Lowdown on Lighting and Cannabis Research
By Early Investing on April 11, 2019
The Early Investing team learned a lot at the Cannabis Science Conference. This week, we’re focusing on two takeaways: lighting and research.